Atara Biotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Atara Biotherapeutics, Inc. (ATRA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.030.030.090.110.200.260.31
Short-Term Investments0.020.030.150.260.300.000.00
Cash & Short-Term Investments0.040.050.240.370.500.260.31
Accounts Receivable0.000.030.040.000.000.000.00
Inventory0.010.010.000.000.000.000.00
Other Current Assets0.010.010.010.010.020.090.00
Total Current Assets0.060.100.300.380.520.270.32
Non-Current Assets
Property, Plant & Equipment (Net)0.040.060.070.080.060.010.07
Other Non-Current Assets0.000.000.010.000.000.000.00
Total Non-Current Assets0.040.060.080.080.060.020.07
Total Assets0.110.170.380.470.590.340.39
Current Liabilities
Accounts Payable0.000.000.010.020.010.020.03
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.010.040.050.020.040.000.00
Deferred Revenue0.100.080.010.040.030.000.00
Other Current Liabilities0.020.100.040.050.040.010.01
Total Current Liabilities0.130.140.080.110.080.040.04
Non-Current Liabilities
Long-Term Debt0.030.050.060.030.010.010.00
Other Non-Current Liabilities0.040.040.010.000.000.010.01
Total Non-Current Liabilities0.070.120.200.080.040.020.01
Total Liabilities0.210.260.250.190.130.050.05
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-2.05-1.97-1.69-1.46-1.12-0.82-0.53
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.961.871.821.741.591.110.87
Shares Outstanding0.010.000.000.000.000.000.00
Total Stockholders' Equity-0.10-0.100.130.280.460.290.34
Total Liabilities & Equity0.110.170.380.470.590.340.39